ITEMS IN AFP WITH KEYWORD:
Mar 1, 2017 Issue
Buprenorphine Maintenance vs. Placebo for Opioid Dependence [Medicine by the Numbers]
Buprenorphine causes lower physical dependence, milder withdrawal symptoms, and is less likely to cause an overdose than methadone in the treatment of opioid dependence.
Jan 1, 2017 Issue
Alpha-adrenergic Agonists for the Management of Opioid Withdrawal [Medicine by the Numbers]
Alpha-adrenergic agonists were more efficacious than placebo in the management of opioid withdrawal, but are best reserved as an alternative to methadone.
Oct 1, 2016 Issue
Rural Opioid Use Disorder Treatment Depends on Family Physicians [Graham Center Policy One-Pagers]
The nation's growing opioid use disorder epidemic disproportionately impacts rural areas, where physicians who can prescribe buprenorphine are scarcest. Among physicians approved to prescribe buprenorphine, family physicians (FPs) are the most likely to work in rural areas.
Find out how to determine the balance of risks and harms from long-term therapy, and when and how to taper therapy.
A woman with a long history of cocaine use presented to the emergency department with leg ulcers and ecchymoses on her ears.
Jul 1, 2015 Issue
Nicotine Replacement Therapy for Smoking Cessation [Medicine by the Numbers]
Studies show that 1 in 15 patients successfully quit smoking and 1 in 94 patients experienced chest pain or palpitations. Want to know more?
Jun 15, 2015 Issue
Primary Care Behavioral Interventions to Reduce Illicit Drug and Nonmedical Pharmaceutical Use in Children [Putting Prevention into Practice]
J.P. is a 16-year-old white female nonsmoker who presents for a sports clearance physical. She is in good overall health, excels academically, and plays water polo at school. During the patient history, she mentions that she and three friends were suspended from school for drinking cough syrup after a water polo tournament.
Mar 1, 2015 Issue
Primary Care Behavioral Interventions to Reduce Illicit Drug and Nonmedical Pharmaceutical Use in Children and Adolescents: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care–based behavioral interventions to prevent or reduce illicit drug or nonmedical pharmaceutical use in children and adolescents. This recommendation applies to children and adoles...
Feb 1, 2015 Issue
Buprenorphine Maintenance vs. Methadone Maintenance or Placebo for Opioid Use Disorder [Cochrane for Clinicians]
At dosages greater than 2 mg per day, buprenorphine maintains treatment retention better than placebo. When flexible dosing (doses adjusted based on patient symptoms) is used, the effectiveness of buprenorphine is comparable to that of methadone in suppressing opioid use.
Substance misuse is common among patients in primary care settings. Although it has a substantial health impact, physicians report low levels of preparedness to identify and assist patients with substance use disorders. An effective approach to office-based treatment includes a coherent framework fo...